| Classification models for clear cell renal carcinoma stage progression, based on tumor RNAseq expression trained supervised machine learning algorithms Z Jagga, D Gupta BMC proceedings 8, 1-7, 2014 | 69 | 2014 |
| Supervised learning classification models for prediction of plant virus encoded RNA silencing suppressors Z Jagga, D Gupta PLoS One 9 (5), e97446, 2014 | 19 | 2014 |
| 1H, 13C and 15N NMR assignments of inactive form of P1 endolysin Lyz M Kashyap, Z Jagga, BK Das, A Arockiasamy, NS Bhavesh Biomolecular NMR assignments 6, 87-89, 2012 | 5 | 2012 |
| Efficacy and immune modulation by BXCL701 a dipeptidyl peptidase inhibitor, NKTR-214 a CD122-biased immune agonist with PD1 blockade in murine pancreatic tumors. L Rastelli, S Gupta, Z Jagga, DH Charych, J Zalevsky Journal of Clinical Oncology 36 (15_suppl), 3085-3085, 2018 | 4 | 2018 |
| The synergy between BXCL701, a DPP inhibitor, and immune checkpoint inhibitors discovered using AI and Big Data analytics L Rastelli, S Gupta, A Dahiya, Z Jagga, K Nandabalan, S Upmanyu Cancer Research 77 (13_Supplement), 2629-2629, 2017 | 4 | 2017 |
| Abstract LB-077: Dipeptidyl Peptidase Inhibitor BXCL701 synergizes with an OX40-agonist antibody resulting in synergistic anti-tumor response and survival in an animal model of … N Veena R. Agarwal, John MacDougall, Dimple Bhatia, Snigdha Gupta, Zeenia Zagga Cancer Research 79 (Issue 13), Supplement, pp. LB-0, 2019 | 2 | 2019 |
| Dipeptidyl peptidase inhibitor BXCL701 synergizes with immunomodulatory agents in a preclinical model of colorectal cancer (CRC) by altering the function of various components … V Agarwal, J MacDougall, D Bhatia, S Gupta, Z Jagga, N Keshava, S Seth, ... Journal of Clinical Oncology 37 (15_suppl), e14253-e14253, 2019 | 2 | 2019 |
| Machine learning for biomarker identification in cancer research-developments toward its clinical application (vol 12, pg 371, 2015) Z Jagga, D Gupta Personalized Medicine 12 (6), 604-604, 2015 | 2 | 2015 |
| 25 Potential predictive biomarkers for BXCL701 in acute myeloid leukemia (AML) V Agarwal, S Trivedi, D Bhatia, Z Jagga, M Donkor, V O’Neill Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
| The dipeptidyl peptidase inhibitor BXCL701 activates innate immunity followed by adaptive immunity on a molecular and cellular level in a mouse model of pancreatic cancer V Agarwal, J MacDougall, shubhendu Trivedi, D Bhatia, Z Jagga, ... Cancer Research 80 (16_Supplement), 962-962, 2020 | | 2020 |
| H, 13 C and 15 N NMR assignments of inactive form of P1 endolysin Lyz M Kashyap, Z Jagga, BK Das, A Arockiasamy, NS Bhavesh | | 2011 |
Dinesh GuptaICGEB在 icgeb.res.in 的电子邮件经过验证
